Tapering off Inhaled Corticosteroids in Asthma patients after Reducation of Allergens.

Does allergen avoidance allow tapering off inhaled coricosteroids in allergic asthmatic patients?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23474

Enrollment

150

Registered

2005-09-12

Start date

1999-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Allergic) asthma.

Interventions

All patients have been trained to use a self-management plan to adjust the dose of inhaled corticosteroids to symptoms and peak expiratory flow value. After a run-in period of 3 months the interventi

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age of 16-60 year; 2. Treatment for asthma by the GP; 3. Use of inhaled corticosteroids; 4. Allergy for house dust mite allergens.

Exclusion criteria

Exclusion criteria: 1. Serious diseases other than asthma with; 2. A low survival rate; 3. Other diseases, which influence bronchial symptoms and/ or lung function; 4. Exacerbation within one month before the start of the study; 5. The use of oral steroids or inhaled cromoglycates; 6. Use of house dust mite impermeable mattress/bedding covers; 7. Allergy to cats or dogs while keeping these pets.

Design outcomes

Primary

Measure	Time frame
Use of inhaled corticosteroids.	—

Secondary

Measure	Time frame
1. Asthma control; 2. Symptoms (dyspnoea, wheezing, coughing); 3. Peak flow parameters (morning peak flow, peak flow variability).	—

Contacts

Public ContactC.P. Schayck, van

University Maastricht (UM), CAPHRI Research Institute, Department of General Practice, P.O. Box 616

onno.vanschayck@hag.unimaas.nl+31 (0)43 3882446

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)